Kjeldsen S - Search Results

1

Pharmacogenetic implications for eight common blood pressure-associated single-nucleotide polymorphisms.

Hamrefors V, Sjögren M, Almgren P, Wahlstrand B, Kjeldsen S, Hedner T, Melander O. Hamrefors V, et al. Among authors: kjeldsen s. J Hypertens. 2012 Jun;30(6):1151-60. doi: 10.1097/HJH.0b013e3283536338. J Hypertens. 2012. PMID: 22525200

2

The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group.

Dahlöf B, Devereux R, de Faire U, Fyhrquist F, Hedner T, Ibsen H, Julius S, Kjeldsen S, Kristianson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H. Dahlöf B, et al. Among authors: kjeldsen s. Am J Hypertens. 1997 Jul;10(7 Pt 1):705-13. Am J Hypertens. 1997. PMID: 9234823 Clinical Trial.

3

Influence of age, sex and blood pressure on the principal endpoints of the Nordic Diltiazem (NORDIL) Study.

Kjeldsen SE, Hedner T, Syvertsen JO, Lund-Johansen P, Hansson L, Lanke J, Lindholm LH, De Faire U, Dahlöf B, Karlberg BE; NORDIL Study Group. Kjeldsen SE, et al. J Hypertens. 2002 Jun;20(6):1231-7. doi: 10.1097/00004872-200206000-00038. J Hypertens. 2002. PMID: 12023696 Clinical Trial.

4

Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study.

Lindholm LH, Ibsen H, Borch-Johnsen K, Olsen MH, Wachtell K, Dahlöf B, Devereux RB, Beevers G, de Faire U, Fyhrquist F, Julius S, Kjeldsen SE, Kristianson K, Lederballe-Pedersen O, Nieminen MS, Omvik P, Oparil S, Wedel H, Aurup P, Edelman JM, Snapinn S; LIFE study group. Lindholm LH, et al. Among authors: kjeldsen se. J Hypertens. 2002 Sep;20(9):1879-86. doi: 10.1097/00004872-200209000-00035. J Hypertens. 2002. PMID: 12195132 Clinical Trial.

5

Comparison of home and office blood pressure in treated hypertensives in the Nordic Diltiazem (NORDIL) Study.

Kjeldsen SE, Hedner T, Syvertsen JO, Lund-Johansen P, Hansson L; NORDIL Group. Nordic Diltiazem. Kjeldsen SE, et al. Blood Press. 2002;11(6):371-6. doi: 10.1080/080370502321095348. Blood Press. 2002. PMID: 12523681 Free article.

6

Contrasting messages but not contradicting results from ALLHAT and ANBP2.

Hedner T, Himmelmann A, Kjeldsen SE. Hedner T, et al. Blood Press. 2003;12(2):68-9. doi: 10.1080/08037050310004658. Blood Press. 2003. PMID: 12797626 Free article. No abstract available.

7

Fasting blood glucose is independently associated with resting and exercise blood pressures and development of elevated blood pressure.

Bjørnholt JV, Erikssen G, Kjeldsen SE, Bodegård J, Thaulow E, Erikssen J. Bjørnholt JV, et al. J Hypertens. 2003 Jul;21(7):1383-9. doi: 10.1097/00004872-200307000-00029. J Hypertens. 2003. PMID: 12817188

8

VALUE trial: Long-term blood pressure trends in 13,449 patients with hypertension and high cardiovascular risk.

Julius S, Kjeldsen SE, Brunner H, Hansson L, Platt F, Ekman S, Laragh JH, McInnes G, Schork AM, Smith B, Weber M, Zanchetti A; VALUE Trial. Julius S, et al. Among authors: kjeldsen se. Am J Hypertens. 2003 Jul;16(7):544-8. doi: 10.1016/s0895-7061(03)00904-x. Am J Hypertens. 2003. PMID: 12850387 Clinical Trial.

9

In light of ALLHAT and ASCOT: are there benefits of statins as add-on treatment in hypertensives?

Kjeldsen SE, Hedner T, Himmelman A. Kjeldsen SE, et al. Blood Press. 2003;12(3):132-3. doi: 10.1080/08037050310008005. Blood Press. 2003. PMID: 12875472 Free article. No abstract available.

10

Recent hypertension guidelines: JNC-7 and 2003 ESH/ESC.

Himmelmann A, Kjeldsen SE, Hedner T. Himmelmann A, et al. Blood Press. 2003;12(4):196-7. doi: 10.1080/08037050310015854. Blood Press. 2003. PMID: 14596354 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

848 results

Search Page

Filters